0001445064-15-000032.txt : 20150203 0001445064-15-000032.hdr.sgml : 20150203 20150203174209 ACCESSION NUMBER: 0001445064-15-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150201 FILED AS OF DATE: 20150203 DATE AS OF CHANGE: 20150203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mallinckrodt plc CENTRAL INDEX KEY: 0001567892 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981088325 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: DAMASTOWN STREET 2: MULHUDDART CITY: DUBLIN STATE: L2 ZIP: 15 BUSINESS PHONE: 353 1 8808180 MAIL ADDRESS: STREET 1: DAMASTOWN STREET 2: MULHUDDART CITY: DUBLIN STATE: L2 ZIP: 15 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Trudeau Mark CENTRAL INDEX KEY: 0001540412 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35803 FILM NUMBER: 15572587 MAIL ADDRESS: STREET 1: COVIDIEN PLC STREET 2: 15 HAMPSHIRE STREET CITY: MANSFIELD STATE: MA ZIP: 02048 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-02-01 0001567892 Mallinckrodt plc MNK 0001540412 Trudeau Mark 675 MCDONNELL BLVD. HAZELWOOD MO 63042 1 1 0 0 President & CEO Ordinary Shares 2015-02-01 4 F 0 3440 105.99 D 157197 D Ordinary Shares 2015-02-02 4 M 0 17904 37.85 A 175101 D Ordinary Shares 2015-02-02 4 S 0 6625 105.51 D 168476 D Ordinary Shares 2015-02-02 4 S 0 4200 106.31 D 164276 D Ordinary Shares 2015-02-02 4 S 0 1100 107.17 D 163176 D Share Options (Right to Buy) 37.85 2015-02-02 4 M 0 17904 0 A 2013-02-01 2022-01-31 Ordinary Shares 17904 17904 D The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on December 4, 2014. This represents the weighted average price paid for the shares. The shares were sold at prices ranging from $104.90 to $105.87, inclusive. Mr. Trudeau will provide, upon request of the SEC staff, Mallinckrodt plc, or a shareholder of Mallinckrodt plc complete information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) - (4) to this Form 4. This represents the weighted average price paid for the shares. The shares were sold at prices ranging from $105.91 to $106.89, inclusive. This represents the weighted average price paid for the shares. The shares were sold at prices ranging from $106.92 to $107.50, inclusive. The options representing rights to purchase 71,616 ordinary shares became exercisable in four equal installments beginning on February 1, 2013, which is the first anniversary from the date of the grant. /s/Peter G. Edwards, Attorney-in-Fact 2015-02-03